Records 1 - 5
| Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder.
The pharmacogenomics journal 2013 Jun 13 (3): 280-5.
Perlis R H, Fijal B, Dharia S, Houston J
| The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder.
Genetic testing and molecular biomarkers 2012 Jul 16 (7): 667-71.
Li Heng-Fen, Yu Xue, Yang Kun, He Cha-Ye, Kou Shao-Jie, Cao Su-Xia, Xie Guang-Ro
| Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
Biological psychiatry 2010 Jun 67 (11): 1110-3.
Perlis Roy H, Fijal Bonnie, Dharia Sweta, Heinloth Alexandra N, Houston John
| Association of PDE11A global haplotype with major depression and antidepressant drug response.
Neuropsychiatric disease and treatment 2009 5 163-70.
Luo Huai-Rong, Wu Gui-Sheng, Dong Chuanhui, Arcos-Burgos Mauricio, Ribeiro Luciana, Licinio Julio, Wong Ma-
| Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.
Proceedings of the National Academy of Sciences of the United States of America 2006 Oct 103 (41): 15124-9.
Wong Ma-Li, Whelan Fiona, Deloukas Panagiotis, Whittaker Pamela, Delgado Marcos, Cantor Rita M, McCann Samuel M, Licinio Jul